|Jul 28 - Aug 20, 1981||Alexander Shulgin first synthesizes 2C-T-2. 1 [More Info]|
|Aug 20, 1981||Alexander Shulgin is the first human to ingests 2C-T-2, at 5mg oral. 1|
|Dec 5, 1981||Shulgin's first group trial with 2C-T-2 where it was determined that the material's appropriate dosage range was 12-25 mg. 1|
|1991||Alexander and Ann Shulgin publish PiHKAL, documenting over 250 phenethylamines, including MDMA, mescaline, 2C-B, 2C-T-7, 2C-T-2, and many others. 2|
|1993||Myron Stolaroff & Charles Wells publish a paper summarizing experiments into the therapeutic potential of 2C-T-7 & 2C-T-2 compared to MDMA. 3|
|Mid 1990's||2C-T-7 and 2C-T-2 are available in very small niche underground groups and therapy circles, not widely available through any commercial vendors. 4|
|Nov 1997||White pills, containing 2C-T-2, are erroneously sold as 2C-T-7 in 'smart shops' in the Netherlands. 5 [More Info]|
- Shulgin AT. Personal communication.
- Shulgin AT, Shulgin A. PiHKAL: A Chemical Love Story. Transform Press. 1991.
- Stolaroff M, Wells C. "Preliminary Results with New Psychoactive Agents 2C-T-2 and 2C-T-7". Yearbook for Ethnomedicine. 1993.
- Erowid internal research
- Murple. "Sulfurous Samadhi". Erowid.org. Feb 6, 2001.